Treatment of acute nonvariceal upper gastrointestinal hemorrhage

Digestion

Volumn 60, Issue SUPPL. 2, 1999, Pages 47-52

  Meier, Rémy ^a   Wettstein, A R ^a  

^a Kantonsspital Liestal   (Switzerland)

Author keywords

Endoscopic treatment; Medical treatment; Octreotide; Risk factors; Somatostatin; Ulcer bleeding, incidence

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; PROTON PUMP INHIBITOR; RANITIDINE; SOMATOSTATIN; TRANEXAMIC ACID;

BLOOD TRANSFUSION; CLINICAL TRIAL; DIGESTIVE SYSTEM HEMORRHAGE; DUODENUM ULCER; ELECTROCOAGULATION; EMERGENCY SURGERY; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HIGH RISK POPULATION; HOSPITAL COST; HOSPITALIZATION; HUMAN; LASER SURGERY; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; REVIEW; STOMACH ULCER;

EID: 0032930169     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051480     Document Type: Review

References (67)

1. Longstreth GF: Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: A population-based study. Am J Gastroenterol 1995;90:206-210.
2. Rockall TA, Logan RFA, Devlin HB, Northfield TC: Incidence of and mortality from acute gastrointestinal haemorrhage in the United Kingdom. BMJ 1995;311:222-226.
3. Yavorski RT, Wong RK, Maydonovitch C, Battin LS, Furnia A, Amundson DE: Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol 1995;90:568-573.
4. Rockall TA, Logan RFA, Devlin HB, Northfield TC: Variation in outcome after acute upper gastrointestinal hemorrhage. Lancet 1995;346: 346-350.
5. Armstrong CP, Blower AL: Non-steroidal antiinflammatory drugs and life-threatening complications of peptic ulceration. Gut 1987;28: 527-532.
6. Henriksson AE, Edman AC, Nilsson I, Bergqvist D, Waldström T: Helicobacter pylori and the relation to other risk factors in patients with acute bleeding peptic ulcer. Scand J Gastroenterol 1998;33:1030-1033.
7. Gyr K, Kayasseh L: Indikation und Verfahrenswahl; in Siewert JR. Blum Al, Farthmann EC, Lankisch PG (eds): Interdisziplinäre Gastroenterologie. Notfalltherapie. Berlin, Springer, 1982, pp 233-245.
8. 2-antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials. N Engl J Med 1985;313:660-666.
9. Terdiman JP, Ostroff JW: Risk of persistent or recurrent and intractable upper gastrointestinal bleeding in the era of therapeutic endoscopy. Am J Gastroenterol 1997;92:1805-1811.
10. Katschinski B, Logan R, Davies J, Faulkner G, Pearson J, Langman M: Prognostic factors in upper gastrointestinal bleeding. Dig Dis Sci 1994;39:706-712.
11. Rockall TA, Logan RFA, Devlin HB, Northfield TC: Selection of patients for early discharge or outpatient care after acute upper gastrointestinal hemorrhage. Lancet 1996;347:1138-1140.
12. Forrest JAH, Finlayson NDC, Shearman DJC: Endoscopy in gastrointestinal bleeding. Lancet 1974;ii:394-397.
13. Ell C, Hagenmüller F, Schmitt W, Riemann JF, Hahn EG, Hohenberger W: Multizentrische prospektive Untersuchung zum aktuellen Stand der Therapie der Ulcusblutung in Deutschland. Dtsch Med Wschr 1995;120:3-9.
14. Griffiths WJ, Neumann DA, Welsh JD: The visible vessel as an indicator of uncontrolled or recurrent gastrointestinal hemorrhage. N Engl J Med 1979;300:1411-1413.
15. Storey DW, Bown SG, Swain CP, Salmon PR, Kirkham JS, Northfield TC: Endoscopic prediction of recurrent bleeding in peptic ulcers. N Engl J Med 1981;305:915-916.
16. Vallon AG, Cotton PB, Laurence BH, Miro JRA, Oses JCS: Randomised trial of endoscopic argon laser photocoagulation in bleeding peptic ulcers. Gut 1981;22:228-233.
17. MacLeod A, Mills PR: Factors identifying the probability of further haemorrhage after acute upper gastrointestinal haemorrhage. Br J Surg 1982;69:256-258.
18. Bornman C, Theodorou NA, Shuttleworth RD, Essel HP, Marks IN: Importance of hypovolaemic shock and endoscopic signs in predicting recurrent haemorrhage from peptic ulceration: A prospective evaluation. Br Med J 1985;291: 245-247.
19. Hasselgren G, Carlsson J, Lind T, Schaffalitzky de Muckadell O, Lundell L: Risk factors for rebleeding and fatal outcome in elderly patients with acute peptic ulcer bleeding. Eur J Gastroenterol Hepatol 1998;10:667-672.
20. Pimpl W, Boeckl O, Waclawiczek HW: Estimation of the mortality rate of patients with severe gastroduodenal hemorrhage with the aid of a new scoring system. Endoscopy 1987;19:101-106.
21. Cook DJ, Guyatt GH, Salena BJ, Laine LA: Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A meta-anlaysis. Gastroenterology 1992;102:139-148.
22. NIH: Consensus Conference: Therapeutic endoscopy and bleeding ulcers. JAMA 1989;262: 1369-1372.
23. Chung SCS, Leung JWC, Steele RJC, Crofts TJ, Li AKC: Endoscopic injection of adrenaline for acitvely bleeding ulcers: A randomised trial. BMJ 1988;296:1631-1633.
24. Lin HJ, Lee FY, Kang WM, Tsai YT, Lee SD, Lee CH: Heat probe thermocoagulation and pure alcohol injection in massive peptic ulcer haemorrhage: A prospective, randomised controlled trial. Gut 1990;31:753-757.
25. Chung SCS, Leung JWC, Sung KKL, Lo KK, Li AKC: Injection or heat probe for bleeding ulcer. Gastroenterology 1991;100:33-37.
26. Chung SC Leung JWC, Leong HT, Lo KK, Li AKC: Adding a sclerosant to endoscopic epinephrine injection in actively bleeding ulcers: A randomized trial. Gastrointest Endosc 1993; 39:611-615.
27. Lin HJ, Perng CL, Lee SD: Is sclerosant injection mandatory after an epinephrine injection for arrest of peptic ulcer haemorrhage? A prospective, randomised, comparative study. Gut 1993;34:1182-1185.
28. Lin HJ, Perng CL, Lee FY: Endoscopic injection for the arrest of peptic ulcer hemorrhage: Final results of a prospective, randomized comparative trial. Gastrointest Endosc 1993;39:15-19.
29. Saeed ZA, Winchester CB, Michaletz PA, Woods KL, Graham DY: A scoring system to predict rebleeding after endoscopic therapy of nonvariceal upper gastrointestinal hemorrhage, with a comparison of heat probe and ethanol injection. Am J Gastroenterol 1993;88:1842-1849.
30. Llach J, Bordas JM, Salmeron JM, Panes J, Garcia-Pagan JC, Feu F, Navasa Mondelo F, Pique JM, Mas A, Ters J, Rodes J: A prospective randomized trial of heater probe thermocoagulation versus injection therapy in peptic ulcer hemorrhage. Gastrointest Endosc 1996; 43:117-120.
31. Liebermann D: Gastrointestinal bleeding: Initial management. Gastroenterol Clin North Am 1993;22:723-736.
32. Laine L: Rolling review: Upper gastrointestinal bleeding. Aliment Pharmacol Ther 1993;7:207-232.
33. Cormack F, Jouhar AJ, Chakrabarti RR, Fearnley GR: Tranexamic acid in upper gastrointestinal haemorrhage. Lancet 1973;i:1207-1208.
34. Barer D, Ogilvie A, Henry D, Dornfield M, Coggon D, French S, Ellis S, Atkins M, Langman M: Cimetidine and tranexamic acid in treatment of acute upper gastrointestinal-tract bleeding. N Engl J Med 1983;26:1571-1575.
35. Lin HJ, Lo WC, Lee FY, Lee SD: A prospective randomized comparative trial showing that omeprazole prevents rebleeding in bleeding peptic ulcer patients after successful endoscopic therapy. DDW Abstract 1771, 1997.
36. Bosch J, Kravetz D, Rodes J: Effect of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver. Comparison with vasopressin. Gastroenterology 1981;80: 518-525.
37. Bloom SR, Mortimer CH, Thorner MO, Besser GM, Hall R, Gomez-Pan A: Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet 1974; ii:1106-1109.
38. Johansson C, Aly A: Stimulation of gastric mucus output by somatostatin in man. Eur J Clin Invest 1982;12:37-39.
39. Bloom SR, Russel RCG, Barros-D'sa AAJ, Baron JH, Besser GM, Hall R, Coy H, Kastin AJ. Scholly AV: Inhibition of gastrin and gastric acid by growth hormone inhibiting hormone. Gut 1975;16:396-400.
40. Arnold R, Creutzfeldt W: Hemmung der Pentagastrin-induzierten Säuresekretion des Magens beim Menschen durch Somatostatin. Dtsch Med Wochenschr 1975;100:1014-1016.
41. Johansson C, Wissen O, Kollberg B, Uvnäs-Wallensten K, Efendic S: Effects of intragastrically administered somatostatin on basal and pentagastrin stimulated gastric acid secretion in man. Acta Physiol Scand 1978;104:232-234.
42. Whitehouse I, Beglinger Ch, Fried M, Gyr K: The effect of octapeptide somatostatin analogue (SMS 201-995) and Somatostatin-14 (SST-14) on pentagastrin-stimulated gastric acid secretion: A comparative study in man. Hepatogastroenterologica 1984;31:227-229.
43. Loud FB, Holst JJ, Egense E, Petersen B, Christiansen J: Is somatostatin a humoral regulator of the endocrine pancreas and gastric acid secretion in man? Gut 1985;26:445-449.
44. Schrumpf E, Vatn MH, Hanssen KF, Myren J: A small dose of somatostatin inhibits the pentagastrin-stimulated gastric secretion of acid, pepsin and intrinsic factor in man. Clin Endocrinol 1978;8:391-395.
45. Thomas WEG: Somatostatin - The long lost antral chalone. Med Hypoth 1980;6:919-927.
46. Wahren J, Felig P: Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus. Lancet 1976;ii:1213-1216.
47. Arnold R, Lankisch PG: Somatostatin and the gastrointestinal tract. Clin Gastroenterol 1980; 9:733-753.
48. Sonnenberg GE, Keller U, Perruchoud A, Burckhardt D, Gyr K: Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects. Gastroenterology 1981;80:526-532.
49. Kayasseh L, Gyr K, Keller U, Stalder GA, Wall M: Somatostatin and cimetidine in peptic-ulcer haemorrhage: A randomised controlled trial. Lancet 1980;i:844-846.
50. Basile M, Celi S, Parisi A, Castiglione N, Parisi S: Somatostatin in the treatment of severe gastrointestinal bleeding from peptic origin. A multicentric controlled trial. Ital J Surg Sci 1984; 14:31-35.
51. Coraggio F, Scarpato P, Spina M, Lombardi S: Somatostatin and ranitidine in the control of iatrogenic haemorrhage of the upper gastrointestinal tract. Br Med J 1984;289:224.
52. Magnusson I, Ihre T, Johansson C, Seligson U, Törngren S, Uvnäs-Moberg K: Randomised double-blind trial of somatostatin in the treatment of massive upper gastrointestinal hemorrhage. Gut 1985;26:221-226.
53. Antonioli A, Gandolfo M, Rigo GP, Bianchi Porro G, Cheli R, Brancato F, Lazzaroni M, Parodi MC, Maringhini A, Raimundo S, Manenti F: Somatostatin and cimetidine in the control of acute upper gastrointestinal bleeding. A controlled multicenter study. Hepatogastroenterology 1986;33:71-74.
54. Torres AJ, Landa I, Hernandez F, Jover JM, Suarez A, Arias J, Cuberas R, Santoyo J, Fernandez R. Colleja J, Nisa E, Rodriquez JL, Moreno E, Balibrea JL: Somatostatin in the treatment of severe upper gastrointestinal bleeding. A multicentre controlled trial. Br J Surg 1986;73:786-789.
55. Coraggio F, Bertini G, Catalano A, Scarpato P, Gualdieri L: Clinical controlled trial of somatostatin with ranitidine and placebo in the control of peptic hemorrhage of the upper gastrointestinal tract. Digestion 1989;43:190-195.
56. Tulassay Z, Gupta R, Papp J, Bodnar A: Somatostatin versus cimetidine in the treatment of actively bleeding duodenal ulcer: A prospective, randomized controlled trial. Am J Gastroenterol 1989;84:6-9.
57. Galmiche JP, Cassigneul J, Faivre J, Tranvouez JL, Ouvry D, Colin R, Pascal JP, Klepping C: Somatostatin in peptic ulcer bleeding - Results of a double-blind controlled trial. Int J Clin Pharmacol Res 1983;3:379-387.
58. Somerville KW, Henry DA, Davies JG, Hine KR, Hawkey CJ, Langman MJ: Somatostatin in the treatment of haemorrhage and melaena. Lancet 1985;i:130-132.
59. Basso N, Bagarani M, Bracci F, Cucchiara G, Gizzonio D, Grassini G, Percoco M, Procacciante F, Toti F: Ranitidine and somatostatin. Their effects on bleeding from the upper gastrointestinal tract. Arch Surg 1986;121:833-835.
60. Saperas E, Piqué JM, Pérez-Ayuso R, Fuster F, Terés J, Bordas JM, Rodes J: Somatostatin compared with cimetidine in the treatment of bleeding peptic ulcer without visible vessel. Aliment Pharmacol Ther 1988;2:153-159.
61. Bauer W, Briner U, Doepfner W, Haller R, Hugnenin R, Marbach P, Petcher TJ, Pless J: Octreotide: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 1982;31:1133-1140.
62. Kutz K, Nüesch E, Rosenthaler J: Pharmacokinetics of SMS 201-995 in healthy subjects. Scand J Gastroenterol 1986;21(suppl):65-72.
63. Wahren J, Eriksson LS: The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis. Scand J Gastroenterol 1986;21(suppl 119):103-108.
64. Christiansen J, Yotis A: The role of somatostatin and a long-acting analogue, SMS 201-995, in acute bleeding due to peptic ulceration. Scand J Gastroenteol 1986;21(suppl 119):109-114.
65. Christiansen J, Ottenjann R, Von Arx F: Placebo-controlled trial with the somatostatin analogue SMS 201-995 in peptic ulcer bleeding. Gastroenterology 1989;97:568-574.
66. Lin HJ, Perng CL, Wang K, Lee CH, Lee SD: Octreotide for arrest of peptic ulcer hemorrhage - A prospective, randomized controlled trial. Hepatogastroenterology 1995;42:856-860.
67. 2-antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: A metaanalysis. Ann Intern Med 1997;127:12:1062-1071.